TMFLilDebbie

Shannon Jones

General Information

Name:
Shannon Jones
Fool Since:
August 18 2015
Aliases:
TMFMPius (3/3/2017), TMFLittleDebbie (3/3/2017)
Where I Live:
Alexandria, VA

Investing Basics

Investing Experience:
Medium High
Risk Tolerance:
Medium High
Investing Style:
Motley (i.e. Anything goes!)
Portfolio Size:
Large (12 or more Stocks)
Types of Investments:
Love small/mid-cap companies with a high potential for growth. Particular interest in biopharma but balanced with a sprinkling of tech and financial positions.
Stocks I Own:
ONCE, BLCM, AIEQ, BRK.B, AMZN, JNJ, V, SQ, MRK, MJ, DIS, OGI, KSHB, IIPR, CBWTF, ORHOF, STZ

Investing Favorites

Industries:
Biopharma, financials/fintech, tech, cannabis
Books:
Financial Shenanigans by H. Schilit, The Little Book of Valuation, Inside The FDA, The Intelligent Investor
Newsletters:
Rule Breakers, Supernova
People:
Aswath Damodaran, David Gardner, Tom Gardner,

Education And Work Information

School(s) Attended
East Carolina University - B.S. Neuroscience, Northeastern University - M.S. Regulatory Affairs for Drugs, Biologics, and Medical Devices, Northeastern University - M.S. in Finance
Former Jobs
Recovering Biotech Employee and Federal Government Worker

Interests

Favorite Vacation Spots:
Charleston, SC & Hawaii
Favorite Sports or Teams:
Carolina Panthers (#Keep Pounding!)

TMFLilDebbie is following 1 Fool

My Story

I've had always had a passion for science. The complexities of the human body absolutely fascinate me. After studying neuroscience in college, I went to work for a biotech company and it was there that I fell in love with the intersection of science and business. I love analyzing biopharma strategy...everything from the early phases of clinical development to commercialization. Biotech keeps you humble, both as an investor and as a science enthusiast. New developments happen everyday in this field. As a result, my own personal Motley is... "Never Graduate!"

How I Invest

As once spoken by a respected biotech CEO...."Look for good, sound science first...the rest will follow." My investing has evolved though. Sound science is a crucial first step. Looking for companies with sound science AND sound commercial viability are keys to winning the long game in biopharma.

The Motley Fool respects your privacy and strive to be transparent about our data collection practices. We use your information to customize the site for you, to contact you about your membership, provide you with promotional information, and in aggregate to help us better understand how the service is used. For more details, please review our Privacy Policy.